Sources
![]() Telstra Health to fully own pharma tech provider Fred IT
MobiHealthNews - (Thursday May 30, 2024) Telstra Health is set to fully acquire pharmacy IT solutions provider Fred IT Group. The company, which has been holding 50% interest in Fred IT since 2013, disclosed in a media release that it will… ![]() Inside the Tech El Camino Health Is Using to Fight the Nurse Burnout Crisis – MedCity News
MedCity News - (Thursday May 30, 2024) Before she became the CIO of Bay Area-based El Camino Health, Deb Muro was a practicing nurse. She knows firsthand just how stressful and draining the nursing profession can be — which is part… |
![]() Platforms Instead of Practices:: Andy Colbert with Ziegler Investments by The Digital Health Roundtable
The Digital Health Roundtable - (Thursday May 30, 2024) A regular panel discussion including the brightest minds in the healthcare industry. With a focus on digital health, DHR holds collaborative conversations with physicians, patients, scientists, creatives, technologists, and executives devoting their efforts to… ![]() The Chief AI Officer in Healthcare: Strategy, Tactics and Evangelism
HealthTech Magazine - (Thursday May 30, 2024) Parminder Bhatia, CAIO of GE HealthCare, says that CAIOs play a crucial role in leading data science, AI, machine learning (ML) and engineering teams while providing a long-term strategic vision and alignment for organizations. |
![]() #HIMSS24Europe Startup PitchFest winners
HIMSS - (Thursday May 30, 2024) We love a speedy pitch! 🏃♂️💨Ellie Paton caught up with our PitchFest winners Neill Dunwoody, Paweł Elbanowski, and Peter Stas at #HIMSS24Europe to get a quick breakdown of their presentations.Here's what they shared, in… ![]() Deep learning to assess microsatellite instability directly from histopathological whole slide images in endometrial cancer
npj Digital Medicine - (Wednesday May 29, 2024) Molecular classification, particularly microsatellite instability-high (MSI-H), has gained attention for immunotherapy in endometrial cancer (EC). MSI-H is associated with DNA mismatch repair defects and is a crucial treatment predictor. The NCCN guidelines recommend pembrolizumab… |
![]() Study: Yale researchers reveal ChatGPT shows racial bias
MobiHealthNews - (Wednesday May 29, 2024) Two ChatGPT models simplified radiology reports at drastically different reading levels when researchers included the inquirer’s race in the prompt, according to a study published by Clinical Imaging.Yale researchers asked GPT-3.5 and GPT-4 to… ![]() Medable Partners with Masimo to Bring Wearable Devices to Clinical Research, Capturing Better Data
HIT Consultant - (Wednesday May 29, 2024) What You Should Know: – Medable Inc., a leader in modern clinical trial technology, has announced a groundbreaking partnership with Masimo (NASDAQ: MASI) to integrate medical-grade wearable devices into clinical research. This collaboration aims to… |
![]() New AI Test Aims to Improve Breast Cancer Recurrence Prediction
HIT Consultant - (Wednesday May 29, 2024) What You Should Know: – A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for… ![]() What are the big health IT regulations that are impacting patient access? #shorts
Healthcare IT Today - (Wednesday May 29, 2024) #healthcareitvideointerviews #healthdatasharing #healthcareai #healthcaregenerativeai #healthcareitvideointerviews #healthcarepricetransparency #healthcarescenefeatured #healthcaretransparency #himss#himss2024 #himss24 24 #onc #priorauth #priorauthorization #tefca #unblockhealth #colinbanas… |












